ATE278405T1 - 1,4-dihydropyridinderivate als inhibitoren einer sehunterfunktion, hervorgerufen durch eine sehnervzellenverletzung, die durch andere faktoren als optischen durchblutungstörungen induziert wird. - Google Patents

1,4-dihydropyridinderivate als inhibitoren einer sehunterfunktion, hervorgerufen durch eine sehnervzellenverletzung, die durch andere faktoren als optischen durchblutungstörungen induziert wird.

Info

Publication number
ATE278405T1
ATE278405T1 AT00915483T AT00915483T ATE278405T1 AT E278405 T1 ATE278405 T1 AT E278405T1 AT 00915483 T AT00915483 T AT 00915483T AT 00915483 T AT00915483 T AT 00915483T AT E278405 T1 ATE278405 T1 AT E278405T1
Authority
AT
Austria
Prior art keywords
optical
visual
caused
defunction
inhibitors
Prior art date
Application number
AT00915483T
Other languages
English (en)
Inventor
Mitsuyoshi Azuma
Yukuo Yoshida
Yuji Sakamoto
Original Assignee
Senju Pharma Co
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Kyoto Pharma Ind filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE278405T1 publication Critical patent/ATE278405T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AT00915483T 1999-04-14 2000-04-11 1,4-dihydropyridinderivate als inhibitoren einer sehunterfunktion, hervorgerufen durch eine sehnervzellenverletzung, die durch andere faktoren als optischen durchblutungstörungen induziert wird. ATE278405T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10642599 1999-04-14
PCT/JP2000/002348 WO2000061148A1 (fr) 1999-04-14 2000-04-11 Inhibiteurs d'hypofonction optique provoquee par une lesion d'une cellule du nerf optique induite par des facteurs autres que les troubles circulatoires optiques

Publications (1)

Publication Number Publication Date
ATE278405T1 true ATE278405T1 (de) 2004-10-15

Family

ID=14433315

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915483T ATE278405T1 (de) 1999-04-14 2000-04-11 1,4-dihydropyridinderivate als inhibitoren einer sehunterfunktion, hervorgerufen durch eine sehnervzellenverletzung, die durch andere faktoren als optischen durchblutungstörungen induziert wird.

Country Status (5)

Country Link
EP (1) EP1181934B1 (de)
AT (1) ATE278405T1 (de)
CA (1) CA2369299A1 (de)
DE (1) DE60014629T2 (de)
WO (1) WO2000061148A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0688973B2 (ja) * 1987-03-12 1994-11-09 京都薬品工業株式会社 １，４−ジヒドロピリジン誘導体
JPH03145464A (ja) * 1989-10-30 1991-06-20 Kyoto Yakuhin Kogyo Kk 光学活性１，４―ジヒドロピリジン誘導体
AU4246793A (en) * 1992-05-13 1993-12-13 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents
US6451799B1 (en) * 1996-10-28 2002-09-17 Senju Pharmaceutical Co., Ltd. Drugs for ameliorating ocular circulatory disorders

Also Published As

Publication number Publication date
EP1181934A4 (de) 2003-11-05
CA2369299A1 (en) 2000-10-19
DE60014629D1 (de) 2004-11-11
EP1181934B1 (de) 2004-10-06
DE60014629T2 (de) 2006-02-23
WO2000061148A1 (fr) 2000-10-19
EP1181934A1 (de) 2002-02-27

Similar Documents

Publication Publication Date Title
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
DK1357111T3 (da) 2-pyridonderivater med affinitet for cannabinoid type 2-receptor
DE69923300D1 (de) Cycloalken-derivate, verfahren zu ihrer herstellung und ihre verwendung
KR930700106A (ko) 혈전증 치료제 및 포스포 디에스테라제 저해제
DK1847534T3 (da) Thiadiazolin-derivater til behandling af kræft
KR850003719A (ko) 시아노피라졸 제초제에 대한 개량
ATE71619T1 (de) Pyridazinon-derivate.
ATE113035T1 (de) 1,4-dihydropyridin-derivate und diese enthaltende pharmazeutische zusammensetzungen.
ATE109134T1 (de) Alkylen-diamine.
EP0309425A3 (de) Heterozyklische Derivate
ATE278405T1 (de) 1,4-dihydropyridinderivate als inhibitoren einer sehunterfunktion, hervorgerufen durch eine sehnervzellenverletzung, die durch andere faktoren als optischen durchblutungstörungen induziert wird.
DK0382463T3 (da) Maleimidforbindelser og fungicider indeholdende dem
DE60041963D1 (de) Inhibitoren einer augendruck-erhöhung durch laserbestrahlung, die 1,4-dihydropyridin-derivate enthalten
DE68922145D1 (de) Herbizide Acrylonitrilderivate.
ATE92468T1 (de) Zimtsaeureamid-derivate.
KR920012100A (ko) 비스포스폰산 유도체, 이의 제조 및 용도
KR880006164A (ko) 1-아릴옥시-3-아미노-2-프로판올, 이의 제조 방법 및 용도
KR880005118A (ko) 디하이드로피리딘 유도체
EP0348505A4 (de) N-(1-thienyläthyl)amin-derivate sowie unkrautvertilgende mittel, die diese als aktive mittel enthalten.
TH27321B (th) ไบรไคเนติกออก เซไดเอซอล
KR950025037A (ko) 신규의 치환된 이미다졸 유도체 및 그의 제조방법

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties